We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Signal Disruption Causes Some Ovarian Cancers

By Biotechdaily staff writers
Posted on 21 Apr 2005
A recent study has revealed that ovarian cancer in women bearing a mutated form of the BRCA1 gene is caused by disruption of biochemical signaling that also disrupts granulosa cell regulation of epithelial cell growth.

BRCA1, known as the breast cancer gene, not only gives carriers of its mutated form an 80% chance of developing breast cancer, it also confers a 40% percent risk of developing ovarian cancer by the age of 70.

Investigators at the University of Southern California (USA) developed a line of mice lacking the BRCA1gene only in their ovarian granulosa cells. More...
These mice were found to be prone to development of ovarian tumors. However, the tumors did not arise in granulosa tissue. Rather, the tumors originated in epithelial tissue, and they carried normal BRCA1 genes. These findings were published in the March 29, 2005, issue of Current Biology.

"Before, we thought this gene was a classical tumor suppressor,” said senior author Dr. Louis Dubeau, professor of pathology at the University of Southern California. "If that were the case, it would mean that mutation of the gene would allow the cell it is in to grow out of control and create a tumor. Instead, what we have shown is that the gene actually acts indirectly, that it disrupts interactions between different cell types. The consequence of this finding is that ovarian cancer is the result of some biochemical problem that may be correctable or preventable. That is what makes this finding so exciting.”



Related Links:
University of Southern California

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette Calibration System
Artel PCS®
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Longitudinal Heart Stress Assessment Improves Prediction of Cardiovascular Outcomes

Accurately predicting cardiovascular disease (CVD) risk in older adults is challenging when assessments rely on single, point-in-time biomarker measurements. Dynamic indicators that reflect evolving cardiac... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.